Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 91 of 144 pages ‹ First < 89 90 91 92 93 > Last ›
HSL6418
Blackwell T.
Free flu vaccine fails to reduce cases study: 'Rates haven't decreased and there's been lots of money spent'
National Post 2006 May 2
HSL10046
Elias M.
New antipsychotic drugs carry risks for children
USA Today 2006 May 2
http://www.usatoday.com/news/health/2006-05-01-atypical-drugs_x.htm
HSL2305
Zoutman DE, Ford BD, Bassili AR
Prescription data
Canadian Medical Association Journal 2006 May 01; 164:(10):1410-1409
HSL2323
Sukkari S, Sasich L D.
Cisapride and patient information leaflets
Canadian Medical Association Journal 2001 May 01; 164:(9):1276-1278
HSL4540
Psychiatric drugs harming Canadians: report
CBC News Online 2006 May 1
http://www.cbc.ca/story/science/national/2006/05/01/psychiatric-drugs060501.html
HSL4541
SSRI antidepressants link to higher suicide risk in seniors
CBC News Online 2006 May 1
http://www.cbc.ca/story/science/national/2006/05/01/ssri-suicide060501.html
HSL4974
Shankar PR, Dubey AK, Subish P.
Critical evaluation of drug promotion using role-plays.
Med Educ 2006 May 01; 40:(5):472
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2929.2006.02429.x
HSL5087
[No authors listed].
Second FDA panel advises on stimulants.
Child Health Alert 2006 May 01; 24:4:
HSL5138
Baumgarten RK.
Drug labels should evolve with medical knowledge.
Anesthesiology 2006 May 01; 104:(5):1107
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200605000-00035
HSL5139
Moore DC.
Labeling (package insert): meaning by the Food and Drug Administration of not recommended, not indicated, and off-label use.
Anesthesiology 2006 May 01; 104:(5):1107
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200605000-00036
HSL5140
Sosis MB.
Package inserts are a must read for anesthesiologists.
Anesthesiology 2006 May 01; 104:(5):1106
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3159&uid=16645469&db=PubMed&url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00000542-200605000-00034
HSL5148
Grossman D, Ellertson C, Abuabara K, Blanchard K, Rivas FT.
Barriers to contraceptive use in product labeling and practice guidelines.
Am J Public Health 2006 May 01; 96:(5):791-9
http://www.ajph.org/cgi/content/full/96/5/791
HSL5206
Ziegler R.
[Benefits and risks of drug industry 'sponsorship'].
Med Monatsschr Pharm.2006 May;29(5):193-4 2006 May 01; 29:(5):193-4
HSL5207
Heinzl S.
[The uses of clinical studies].
Med Monatsschr Pharm 2006 May 01; 29:(5):157
HSL5217
Novas C.
What is the bioscience industry doing to address the ethical issues it faces?
PLoS Med 2006 May 01; 3:(5):e142
http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=16573362
HSL5218
Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA.
Lessons on ethical decision making from the bioscience industry.
PLoS Med 2006 May 01; 3:(5):e129
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0030129
HSL5391
Dunn JD, Cannon E, Mitchell MP, Curtiss FR.
Utilization and drug cost outcomes of a step-therapy edit for generic antidepressants in an HMO in an integrated health system.
J Manag Care Pharm 2006 May 01; 12:(4):294-302
HSL5551
Ohbayashi H.
[Results of a survey questionnaire concerning smoking conditions in 54 major Japanese pharmaceutical companies and among their employees].
Nihon Kokyuki Gakkai Zasshi 2006 May 01; 44:(5):374-83
HSL5552
Electronic chip fights counterfeiting.
AIDS Patient Care STDS 2006 May 01; 20:(5):380-1
HSL5562
Ali MH, Kalima P, Maxwell SR.
Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres.
J Antimicrob Chemother 2006 May 01; 57:(5):959-62
http://jac.oxfordjournals.org/cgi/content/full/57/5/959
HSL5563
Gardarsdottir H, Heerdink ER, Egberts AC.
Potential bias in pharmacoepidemiological studies due to the length of the drug free period: a study on antidepressant drug use in adults in the Netherlands.
Pharmacoepidemiol Drug Saf 2006 May 01; 15:(5):338-43
http://www3.interscience.wiley.com/cgi-bin/abstract/112466084/ABSTRACT?CRETRY=1&SRETRY=0
HSL5653
Dresser R.
Pharmaceutical company gifts: from voluntary standards to legal demands.
Hastings Cent Rep 2006 May-Jun 01; 36:(3):8-9
HSL5654
Shiwani MH.
Quest of prescribing practice in Pakistan.
J Pak Med Assoc 2006 May 01; 56:(5):249-50
HSL5664
Brock DW.
How much is more life worth?
Hastings Cent Rep 2006 May-Jun 01; 36:(3):17-9
HSL5668
Collis MC.
Integrative pharmacology and drug discovery--is the tide finally turning?
Nat Rev Drug Discov 2006 May 01; 5:(5):377-9
http://www.nature.com/nrd/journal/v5/n5/abs/nrd2036.html;jsessionid=2E66E474982DC1C9B107D97A21F5C060
HSL5669
Mahecha LA.
Rx-to-OTC switches: trends and factors underlying success.
Nat Rev Drug Discov 2006 May 01; 5:(5):380-5
http://www.nature.com/nrd/journal/v5/n5/abs/nrd2028.html
HSL5766
Jayaraman J.
Whose pen is in your pocket?
Can Fam Physician 2006 May 01; 52:586
HSL5767
Cole D.
Whose pen is in your pocket?
Can Fam Physician 2006 May 01; 52:586
HSL5768
Williams R, Marion J.
Are drug too expensive in Canada? No
Can Fam Physician 2006 May 01; 52:573-6, 578-81
HSL5769
Lexchin J.
Are drugs too expensive in Canada? Yes
Can Fam Physician. 2006 May 01; 52:573-6, 578-81
http://web.archive.org/web/20081201092146/http://www.cfpc.ca/cfp/2006/May/vol52-may-debates-1.asp?
HSL5770
Noehrenberg E.
Report of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective.
Bull World Health Organ 2006 May 01; 84:(5):419-20
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500027&lng=en&nrm=iso&tlng=en
HSL5771
Aoki R, Kubo K, Yamane H.
Patent policy and public health in developing countries: lessons from Japan.
Bull World Health Organ 2006 May 01; 84:(5):417-8
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500026&lng=en&nrm=iso&tlng=en
HSL5772
Winters DJ.
Expanding global research and development for neglected diseases.
Bull World Health Organ 2006 May 01; 84:(5):414-6
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500025&lng=en&nrm=iso&tlng=en
HSL5773
Maurer SM.
Choosing the right incentive strategy for research and development in neglected diseases.
Bull World Health Organ 2006 May 01; 84:(5):376-81
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000500017&lng=en&nrm=iso&tlng=en
HSL5774
Lee ET, O'Riordan D, Swetter SM, Demierre MF, Brooks K, Geller AC.
Sun care advertising in popular U.S. magazines.
Am J Health Promot 2006 May-Jun 01; 20:(5):349-52
HSL5775
Burkitt JA, Saucier DM, Thomas NA, Ehresman C.
When advertising turns 'cheeky'!
Laterality 2006 May 01; 11:(3):277-86
http://taylorandfrancis.metapress.com/(2l2xmgqnf5koknqxuljfhlax)/app/home/contribution.asp?referrer=parent&backto=issue,5,7;journal,4,47;linkingpublicationresults,1:101905,1
HSL5819
Skomo ML, Desselle SP, Berdine HJ.
Factors influencing migraineur-consulting behavior in a university population.
Headache 2006 May 01; 46:(5):742-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1526-4610.2006.00431.x
HSL5964
Modernizing medical product development through collaboration.
FDA Consum 2006 May-Jun 01; 40:(3):5
http://www.fda.gov/fdac/departs/2006/306_upd.html
HSL5993
Edwards M, Murray F, Yu R.
Gold in the ivory tower: equity rewards of outlicensing.
Nat Biotechnol 2006 May 01; 24:(5):509-15
HSL5994
Kamarck ME.
Building biomanufacturing capacity--the chapter and verse.
Nat Biotechnol 2006 May 01; 24:(5):503-5
http://www.nature.com/nbt/journal/v24/n5/abs/nbt0506-503.html
HSL5995
Saberwal G.
New pharma-biotech company formation in India.
Nat Biotechnol 2006 May 01; 24:(5):499-501
http://www.nature.com/doifinder/10.1038/nbt0506-499b
HSL5996
Ransom J.
Are small biotechs still underselling themselves?
Nat Biotechnol 2006 May 01; 24:(5):477
http://www.nature.com/doifinder/10.1038/nbt0506-477
HSL6049
Kids are different.
Profiles Healthc Commun 2006 May-Jun 01; 22:(3):20-4,
HSL6050
GE Healthcare launches multiphase advertising effort.
Profiles Healthc Commun 2006 May-Jun 01; 22:(3):11-9,
HSL6051
Michigan health system launches integrated campaign using patient testimonials.
Profiles Healthc Commun 2006 May-Jun 01; 22:(3):1-9,
HSL6084
Bundesministerium fur Gesundheit.
[Regulation for control of advertising cosmetic operations set into effect].
Kinderkrankenschwester 2006 May 01; 25:(5):211
HSL6138
Service FJ.
Idle thoughts from an addled mind. Caveat medicus.
Endocr Pract 2006 May-Jun 01; 12:(3):341
http://aace.metapress.com/(nlhpdn55bgfe0s45s03jwbas)/app/home/contribution.asp?referrer=parent&backto=issue,16,19;journal,4,79;linkingpublicationresults,1:300404,1
HSL6142
Cowden AL, Katz KA.
Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
Br J Dermatol 2006 May 01; 154:(5):950-8
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2006.07168.x
HSL6182
Stagnaro JC.
[The discovery of therapeutic properties of lithium].
Vertex 2006 May-Jun 01; 17:(67):225-30
HSL6183
Bignone IM.
[Issues regarding the legal regulation of drugs in Argentina].
Vertex 2006 May-Jun 01; 17:(67):220-3
HSL6268
Shulman LP, Bateman LH, Creinin MD, Cullins VE, Doyle LL, Godfrey E, Murphy P, Rodriguez P, Spear SJ, Stewart FH, Thomas MA, Westhoff CL, Worthington S.
Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labeling.
Contraception 2006 May 01; 73:(5):440-2
http://linkinghub.elsevier.com/retrieve/pii/S0010-7824(06)00034-5
HSL4610
McCaughan , M .
Time to pay the piper? Industry prepares for a fight over user fees.
The RPM report 2006 May; 1:(6):
http://www.windhover.com/ezine/pdf/UserFees0605.pdf
HSL4705
Ban TA.
Academic psychiatry and the pharmaceutical industry.
Prog Neuropsychopharmacol Biol Psychiatry 2006 May; 30:(3):429-41
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16442686&db=pubmed&url=http://linkinghub.elsevier.com/retrieve/pii/S0278-5846(05)00363-5
HSL5051
Hu A, Chow CM, Dao D, Errett L, Keith M.
Factors influencing patient knowledge of warfarin therapy after mechanical heart valve replacement.
J Cardiovasc Nurs 2006 May-Jun; 21:(3):169-75
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005082-200605000-00003
HSL5055
Schneeman B, Trumbo P, Ellwood K, Satchell F.
The regulatory process to revise nutrient labeling relative to the Dietary Reference Intakes.
Am J Clin Nutr 2006 May; 83:(5):1228S-1230S
http://www.ajcn.org/cgi/content/full/83/5/1228S
HSL5059
Larson K, Levy J, Rome MG, Matte TD, Silver LD, Frieden TR.
Public health detailing: a strategy to improve the delivery of clinical preventive services in New York City.
Public Health Rep 2006 May-Jun; 121:(3):228-34
HSL5069
The future should not look like the past.
Lancet Infect Dis 2006 May; 6:(5):253
http://linkinghub.elsevier.com/retrieve/pii/S1473-3099(06)70441-8
HSL7265
Burgos A.
[Spanish code of good practice for medicinal drug promotion: a deontological supervision unit].
Farm Hosp. 2006 May-June; 30:(3):137-8
http://www.grupoaran.com/mrmUpdate/lecturaPDFfromXML.asp?IdArt=458130&TO=RVN&Eng=0http://
HSL7435
Tom G, Ramil E, Zapanta I, Demir K, Lopez S.
The role of overt head movement and attention in persuasion.
J Psychol 2006 May; 140:(3):247-53
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16916077&query_hl=26&itool=pubmed_DocSum
HSL7704
Otoom SA, Sequeira RP.
Health care providers' perceptions of the problems and causes of irrational use of drugs in two Middle East countries.
Int J Clin Pract 2006 May; 60:(5):565-70
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1742-1241.2005.00808.x
HSL9259
Balbani AP, Stelzer LB, Montovani JC.
Pharmaceutical excipients and the information on drug labels.
Rev Bras Otorrinolaringol (Engl Ed) 2006 May-Jun; 72:(3):400-6
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72992006000300018&tlng=en&lng=en&nrm=iso
HSL9984
Lexchin J.
Who Should Own the Presses?
Israeli Journal of Emergency Medicine 2006 May; 6:(2):3-5
http://www.isrjem.org/Lexchin.Editorial.proof2.pdf
HSL4618
Griffith D.
More women seek help for attention disorders
The Sacramento Bee 2006 Apr 30
http://www.sacbee.com/content/news/story/14249758p-15066687c.html
HSL4526
Harris G.
Ex-Head of F.D.A. Faces Criminal Inquiry
New York Times 2006 Apr 29
http://www.nytimes.com/glogin?URI=http://www.nytimes.com/2006/04/29/washington/29fda.html&OQ=_rQ3D1Q26pagewantedQ3Dprint&OP=543add1Q2F(WEh(Q2AQ2BkQ3EnQ2BQ2BDI(Iggz(gQ7B(Il(WeQ3EQ3DiadDQ2Ba(IlVQ2AefQ3DDQ27M
HSL4527
LobbyWatch: Lobbying Firm- Policy Directions Inc
The Center for Public Integrity 2006 Apr 29
http://www.publicintegrity.org/lobby/profile.aspx?act=firms&year=2003&lo=L002522
HSL4543
Walkom T.
Can Ontario stand up to Big Pharma?
Toronto Star 2006 Apr 29
http://www.thestar.com/NASApp/cs/ContentServer?pagename=thestar/Layout/Article_Type1&c=Article&cid=1146261012039&call_pageid=968332188774
HSL4537
ACCC proposes to re-authorise code of conduct governing drug companies' dealings with doctors
Australian Competition and Consumer Commission 2006 Apr 28
http://www.accc.gov.au/content/index.phtml/itemId/733026/fromItemId/142
HSL19914
Jenkins R
New code clamps down on specialists' treats
Australian Doctor 2006 Apr 287
http://www.australiandoctor.com.au/news/new-code-clamps-down-on-specialists--8217;-treats
HSL4532
Smith A.
Wyeth faces thousands of Prempro lawsuits
CNN/Money 2006 Apr 27
http://money.cnn.com/2006/04/26/news/companies/wyeth/index.htm?source=yahoo_quote
HSL4997
Brown SD, Daly JC, Kalish LA, McDaniel SA,
Financial Disclosures of Scientific Papers Presented at the 2003 RSNA Annual Meeting: Association with Reporting of Non–Food and Drug Administration–approved Uses of Industry Products
: Radiological Society of North America (RSNA) 2006 Apr 26
http://radiology.rsnajnls.org/cgi/content/abstract/2393050744v1?ct&eaf
HSL16752
Lurie P, Almeida CM, Stine N, Stine AR, Wolfe SM.
Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
JAMA 2006 Apr 26; 295:(16):1921-8
http://jama.ama-assn.org/cgi/content/full/295/16/1921
HSL4522
Study: Prescription drug overdoses surpass deaths from illegal drugs
McKnights Long-term Care News & Assisted Living 2006 Apr 25
http://www.mcknightsonline.com/content/index.php?id=24&tx_ttnews[tt_news]=2912&tx_ttnews[backPid]=26&cHash=ba0d3ed9fa
HSL4523
One-third of drug safety advisers in U.S. show conflicts of interest: study
CBC News Online 2006 Apr 25
http://www.cbc.ca/story/science/national/2006/04/25/fda060425.html
HSL4524
Industry unites to spread CoP word.
PMLive.com 2006 Apr 25
http://www.pmlive.com/communique/news.cfm?showArticle=1&ArticleID=4568
HSL4528
Simons J.
Merck's got to keep fighting
CNN/Money ( from Fortune ) 2006 Apr 25
http://money.cnn.com/2006/04/25/news/companies/pluggedin_fortune/index.htm?source=yahoo_quote
HSL4529
UPDATE 1-Wyeth renews push for crackdown on unapproved drugs
Reuters 2006 Apr 25
http://yahoo.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?storyID=urn:newsml:reuters.com:20060426:MTFH84336_2006-04-26_01-02-06_N25226204&symbol=WYE.N&rpc=44
HSL4978
Biron P, Mintzes B, Lexchin J.
Questions about Adderall XR.
CMAJ 2006 Apr 25; 174:(9):1303-4
http://www.cmaj.ca/cgi/content/full/174/9/1303-a
HSL4509
Schneemann K.
Pharmaceutical Benefits Scheme reform can foster medical innovation
The Australian Newspaper 2006 Apr 24
http://www.theaustralian.news.com.au/story/0,20867,18904562-7583,00.html
HSL4511
Mathews A.
Congressional Report Assails FDA on Drug Safety
The wall street journal 2006 Apr 24
http://online.wsj.com/article_email/SB114584152141633740-lMyQjAxMDE2NDI1NDgyNDQxWj.html
HSL4513
Alonso-zaldivar R.
Drug Safety Still Seen as Lagging
Los Angeles Times 2006 Apr 24
http://www.latimes.com/news/nationworld/nation/la-na-fda24apr24,0,1424816.story?coll=la-home-headlines
HSL4514
FDA Panel Investigating Labeling of Antihypertensive Drugs Stacked with Industry Consultants
Center for Science in the Public Interest 2006 Apr 24
http://www.cspinet.org/new/200604241.html
HSL4515
Armstrong D.
Critical Dose Aspirin Dispute Is Fueled by Funds Of Industry Rivals
The Wall Street Journal 2006 Apr 24
http://online.wsj.com/article/SB114583660487933679.html
HSL4520
Bridges A.
Generic Drug Payoff Draws Gov't. Interest
Associated Press 2006 Apr 24
http://biz.yahoo.com/ap/060424/ftc_drugs.html?.v=2
HSL4975
Horn FE, Mandryk JA, Mackson JM, Wutzke SE, Weekes LM, Hyndman RJ.
Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.
Pharmacoepidemiol Drug Saf 2006 Apr 24;
http://www3.interscience.wiley.com/cgi-bin/abstract/112593258/ABSTRACT?CRETRY=1&SRETRY=0
HSL4510
Harris G.
Congressional Investigators Are Critical of F.D.A.'s Efforts to Detect Drug Dangers
New York Times 2006 Apr 23
http://select.nytimes.com/gst/tsc.html?URI=http://select.nytimes.com/mem/tnt.html&OQ=_rQ3D2Q26tntgetQ3D2006Q2F04Q2F24Q2FwashingtonQ2F24fda.htmlQ26tntemail0Q3DyQ26orefQ3DloginQ26emcQ3DtntQ26pagewantedQ3Dprint&OP=4fcc415Q2FzcqrzQ2AUXqQ60Q5BMz_XeQ60hhQ2A4zXQ2AhQ7EgXq_XqQ5BzXKXyQ24XMQ7D
HSL4507
Drug trials outsourced to India
BBC News 2006 Apr 22
http://news.bbc.co.uk/2/hi/south_asia/4932188.stm
HSL4508
Masters C.
Counting cost of super drugs
The Daily Telegraph (Australia) 2006 Apr 22
http://www.dailytelegraph.news.com.au/story/0,20281,18884915-5001022,00.html
HSL5153
Tanne JH.
Court awards claimant 13.5m dollars in rofecoxib lawsuit
BMJ. 2006 Apr 22; 332:(7547):927
http://bmj.bmjjournals.com/cgi/content/full/332/7547/927-a
HSL5555
Grace M.
Ethical marketing.
Br Dent J 2006 Apr 22; 200:(8):418
http://www.nature.com/doifinder/10.1038/sj.bdj.4813532
HSL5976
Ivanitskaya L, O'Boyle I, Casey AM.
Health information literacy and competencies of information age students: results from the interactive online Research Readiness Self-Assessment (RRSA).
J Med Internet Res 2006 Apr 21; 8:(2):e6
http://www.jmir.org/2006/2/e6/
HSL4435
Carey B.
Study Finds a Link of Drug Makers to Psychiatrists
New York Times 2006 Apr 20
http://select.nytimes.com/gst/tsc.html?URI=http://select.nytimes.com/mem/tnt.html&OQ=_rQ3D2Q26tntgetQ3D2006Q2F04Q2F20Q2FhealthQ2F20psych.htmlQ26tntemail1Q3DyQ26orefQ3DloginQ26emcQ3DtntQ26pagewantedQ3Dprint&OP=3960befaQ2FQ2FQ26Q25rQ2F1-hQ25IHbQ2FthvIDD1Q2BQ2Fh1DnQ5ChQ25thQ25HQ2FhLhsYhbQ3B
HSL5040
Carey B.
Study cites links to firms by psychiatrists.
NY Times (Print) 2006 Apr 20; :A23:
HSL4396
Gibbs F.
Drug company offers £5,000 if victims of trial agree not to sue
Times Online 2006 Apr 19
http://www.timesonline.co.uk/printFriendly/0,,1-2-2140946-61,00.html
HSL4392
Judge seeks FDA ruling on Novartis drug: report
Reuters 2006 Apr 17
http://biz.yahoo.com/rb/060417/novartis_pfizer.html?.v=1
HSL4393
Mondics C.
Drugmakers benefiting from improved political climate
Knight Ridder Newspapers 2006 Apr 17
http://www.twincities.com/mld/twincities/news/politics/14360884.htm
HSL4394
Merck To Appeal Punitive And Compensatory Verdicts In New Jersey VIOXX® Product Liability Case
Medical News Today 2006 Apr 17
http://www.medicalnewstoday.com/medicalnews.php?newsid=41686
HSL4395
Greenspan H.
Michigan liability law a prescription for disaster
Detroit Free Press 2006 Apr 17
http://www.freep.com/apps/pbcs.dll/article?AID=/20060417/OPINION02/604170306/1070/OPINION
HSL4397
Smith R.
Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
PLoS Medicine ( Public Library of Science) 2006 Apr 17
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0020138
HSL4391
Elias P.
Firms in Dispute Over Antiviral Drug
Associated Press 2006 Apr 16
http://biz.yahoo.com/ap/060416/flu_drug_squabble.html?.v=2
HSL4399
Pringle E.
Fosamax Does More Harm Than Good
Media Monitors Network 2006 Apr 16
http://usa.mediamonitors.net/content/view/full/29246
Page 91 of 144 pages ‹ First < 89 90 91 92 93 > Last ›
